These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 25074867)

  • 1. A novel therapeutic use of HFA-BDP metereddose inhaler for asthmatic patients with rhinosinusitis: Case series.
    Kobayashi Y; Asako M; Kanda A; Tomoda K; Yasuba H
    Int J Clin Pharmacol Ther; 2014 Oct; 52(10):914-9. PubMed ID: 25074867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HFA-BDP Metered-Dose Inhaler Exhaled Through the Nose Improves Eosinophilic Chronic Rhinosinusitis With Bronchial Asthma: A Blinded, Placebo-Controlled Study.
    Kobayashi Y; Yasuba H; Asako M; Yamamoto T; Takano H; Tomoda K; Kanda A; Iwai H
    Front Immunol; 2018; 9():2192. PubMed ID: 30337921
    [No Abstract]   [Full Text] [Related]  

  • 3. Replacement of SFC-DPI with SFC-MDI exhaled through the nose improves eosinophilic chronic rhinosinusitis in patients with bronchial asthma.
    Kobayashi Y; Asako M; Yamamoto T; Yasuba H; Tomoda K; Kanda A
    Int J Clin Pharmacol Ther; 2017 Jan; 55(1):89-94. PubMed ID: 27879191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of beclometasone dipropionate/formoterol extra-fine fixed combination on the peripheral airway inflammation in controlled asthma.
    Bulac S; Cimrin A; Ellidokuz H
    J Aerosol Med Pulm Drug Deliv; 2015 Apr; 28(2):82-7. PubMed ID: 25050594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The small airway inflammation of asthmatic patients who have used dry powder type inhaled steroid for moderate-long term evaluated by induced sputum and the efficacy of HFA-BDP (QVAR) inhalation].
    Ohbayashi H
    Arerugi; 2005 Jan; 54(1):24-35. PubMed ID: 15841673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Stabilization of two patients with brittle asthma by inhaled beclomethasone dipropionate with small particle size].
    Köhler D; Haidl P; Kemper P; Schönhofer B
    Pneumologie; 2001 May; 55(5):244-8. PubMed ID: 11449610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of particle size and patient dosing technique on lung deposition of HFA-beclomethasone from a metered dose inhaler.
    Leach CL; Davidson PJ; Hasselquist BE; Boudreau RJ
    J Aerosol Med; 2005; 18(4):379-85. PubMed ID: 16379614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects.
    Chrousos GP; Ghaly L; Shedden A; Iezzoni DG; Harris AG
    Chest; 2005 Jul; 128(1):70-7. PubMed ID: 16002918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switch to non-CFC inhaled corticosteroids: a comparative efficacy study of HFA-BDP and CFC-BDP metered-dose inhalers.
    Demedts M; Cohen R; Hawkinson R
    Int J Clin Pract; 1999; 53(5):331-8. PubMed ID: 10695095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-life effectiveness of extrafine beclometasone dipropionate/formoterol in adults with persistent asthma according to smoking status.
    Brusselle G; Peché R; Van den Brande P; Verhulst A; Hollanders W; Bruhwyler J
    Respir Med; 2012 Jun; 106(6):811-9. PubMed ID: 22357130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrafine beclomethasone/formoterol combination via a dry powder inhaler (NEXThaler(®)) or pMDI and beclomethasone monotherapy for maintenance of asthma control in adult patients: A randomised, double-blind trial.
    Kanniess F; Scuri M; Vezzoli S; Francisco C; Petruzzelli S
    Pulm Pharmacol Ther; 2015 Feb; 30():121-7. PubMed ID: 25088067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung function and asthma control with beclomethasone and formoterol in a single inhaler.
    Huchon G; Magnussen H; Chuchalin A; Dymek L; Gonod FB; Bousquet J
    Respir Med; 2009 Jan; 103(1):41-9. PubMed ID: 18977646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real life clinical study design supporting the effectiveness of extra-fine inhaled beclomethasone/formoterol at the level of small airways of asthmatics.
    Popov TA; Petrova D; Kralimarkova TZ; Ivanov Y; Popova T; Peneva M; Odzhakova T; Ilieva Y; Yakovliev P; Lazarova T; Georgiev O; Hodzhev V; Hodzheva E; Staevska MT; Dimitrov VD
    Pulm Pharmacol Ther; 2013 Dec; 26(6):624-9. PubMed ID: 23769863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative improvement of asthma symptoms and expiratory flows after corticosteroid treatment: a method to assess the effect of corticosteroids on large vs. small airways?
    Boulet LP
    Respir Med; 2006 Mar; 100(3):496-502. PubMed ID: 16039107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrofluoroalkane-beclomethasone dipropionate effectively improves airway eosinophilic inflammation including the distal airways of patients with mild to moderate persistent asthma as compared with fluticasone propionate in a randomized open double-cross study.
    Ohbayashi H; Adachi M
    Allergol Int; 2008 Sep; 57(3):231-9. PubMed ID: 18493166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrafine beclomethasone dipropionate breath-actuated inhaler (400 micrograms/day) versus budesonide dry powder inhaler (800 micrograms/day) in asthma.
    Reichel W; Dahl R; Ringdal N; Zetterstrom O; van den Elshout FJ; Laitinen LA
    Int J Clin Pract; 2001 Mar; 55(2):100-6. PubMed ID: 11321849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of severe persistent bronchial asthma who showed significant improvement by switching to hfa-bdp, with reducing the dosage of oral steroids].
    Ohbayashi H
    Arerugi; 2005 Nov; 54(11):1294-301. PubMed ID: 16407676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting inhaled steroids.
    Leach C
    Int J Clin Pract Suppl; 1998 Sep; 96():23-7. PubMed ID: 10344030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic profile of beclomethasone dipropionate hydrofluoroalkane after intranasal administration versus oral inhalation in healthy subjects: results of a single-dose, randomized, open-label, 3-period crossover study.
    Ratner PH; Melchior A; Dunbar SA; Tantry SK; Dorinsky PM
    Clin Ther; 2012 Jun; 34(6):1422-31. PubMed ID: 22621776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Device mechanics and evaluation of inspiratory flow rate required of the beclomethasone dipropionate breath-actuated inhaler.
    Mansfield LE; Hampel FC; Sfeir B; Small CJ; Walsh D; Dunphy L
    Allergy Asthma Proc; 2019 May; 40(3):162-166. PubMed ID: 31018890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.